These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 10204154)

  • 1. Prostate cancer risk assessment program. A model for the early detection of prostate cancer.
    Bruner DW; Baffoe-Bonnie A; Miller S; Diefenbach M; Tricoli JV; Daly M; Pinover W; Grumet SC; Stofey J; Ross E; Raysor S; Balshem A; Malick J; Engstrom P; Hanks GE; Mirchandani I
    Oncology (Williston Park); 1999 Mar; 13(3):325-34; discussion 337-9, 343-4 pas. PubMed ID: 10204154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancer.
    Uzzo RG; Brown JG; Horwitz EM; Hanlon A; Mazzoni S; Konski A; Greenberg RE; Pollack A; Kolenko V; Watkins-Bruner D
    BJU Int; 2004 May; 93(7):955-60. PubMed ID: 15142142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer risk assessment program: a 10-year update of cancer detection.
    Giri VN; Beebe-Dimmer J; Buyyounouski M; Konski A; Feigenberg SJ; Uzzo RG; Hanks G; Godwin AK; Chen DY; Gordon R; Cescon T; Raysor S; Watkins-Bruner D
    J Urol; 2007 Nov; 178(5):1920-4; discussion 1924. PubMed ID: 17868726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The unintended burden of increased prostate cancer detection associated with prostate cancer screening and diagnosis.
    Albertsen PC
    Urology; 2010 Feb; 75(2):399-405. PubMed ID: 19931892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons Learned from Implementing a Prostate Cancer Risk Assessment Program for Underserved High-Risk Men in the Community: the Prostate REACH Project.
    Fleisher L; Davis SN; Gross L; Bagden L; Zakrzewski D; González E; Kandadai V; Rusten C; Baskett J; Obeid E; Giri VN
    J Cancer Educ; 2016 Mar; 31(1):191-7. PubMed ID: 25971432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing individual risk for prostate cancer.
    Nam RK; Toi A; Klotz LH; Trachtenberg J; Jewett MA; Appu S; Loblaw DA; Sugar L; Narod SA; Kattan MW
    J Clin Oncol; 2007 Aug; 25(24):3582-8. PubMed ID: 17704405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding horizons in breast and prostate cancer prevention and early detection. The 1992 Samuel C. Harvey Lecture.
    Greenwald P; Kramer B; Weed D
    J Cancer Educ; 1993; 8(2):91-107. PubMed ID: 8363943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A framework for the identification of men at increased risk for prostate cancer.
    Roobol MJ; Schröder FH; Crawford ED; Freedland SJ; Sartor AO; Fleshner N; Andriole GL
    J Urol; 2009 Nov; 182(5):2112-20. PubMed ID: 19758625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history.
    McDowell ME; Occhipinti S; Gardiner RA; Chambers SK
    BJU Int; 2012 Apr; 109 Suppl 3():64-70. PubMed ID: 22458497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Cancer Society guideline for the early detection of prostate cancer: update 2010.
    Wolf AM; Wender RC; Etzioni RB; Thompson IM; D'Amico AV; Volk RJ; Brooks DD; Dash C; Guessous I; Andrews K; DeSantis C; Smith RA;
    CA Cancer J Clin; 2010; 60(2):70-98. PubMed ID: 20200110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for prostate cancer.
    Brawley OW; Ankerst DP; Thompson IM
    CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2012 Jul; 157(2):120-34. PubMed ID: 22801674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors, prevention and early detection of prostate cancer.
    Loeb S; Schaeffer EM
    Prim Care; 2009 Sep; 36(3):603-21. PubMed ID: 19616157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families.
    Matikainen MP; Schleutker J; Mörsky P; Kallioniemi OP; Tammela TL
    Clin Cancer Res; 1999 Jun; 5(6):1275-9. PubMed ID: 10389909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical assessment of prebiopsy parameters for predicting prostate cancer metastasis and mortality.
    van Leeuwen PJ; van den Bergh RC; Wolters T; Zhu X; Bul M; Schröder FH; Bangma CH; Roobol MJ
    Can J Urol; 2011 Dec; 18(6):6018-24. PubMed ID: 22166329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community prostate cancer screening.
    Klamet A; Crighton F; Deisher R; Wingate A
    Cancer Pract; 1995; 3(6):366-71. PubMed ID: 15859167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing.
    Bratt O; Kristoffersson U; Lundgren R; Olsson H
    Urology; 1997 Sep; 50(3):360-5. PubMed ID: 9301698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of developing prostate cancer in the future: overview of prognostic biomarkers.
    Fleshner NE; Lawrentschuk N
    Urology; 2009 May; 73(5 Suppl):S21-7. PubMed ID: 19375623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.